Cefazolin Injection, Powder, For Solution
Product Images NDC 71872-7027

3 FDA label images from Medical Purchasing Solutions, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefazolin (NDC 71872-7027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (7027)

Pdp (7027)
Label for Cefazolin for Injection, USP 1 gram per vial, provided by Medical Purchasing Solutions, LLC. The label includes dosage information, administration instructions for intramuscular and intravenous use, storage conditions, and manufacturer details. The label also displays the NDC number 71872-7027-1 and batch/expiry placeholders.*
FDA Label Image

Chemical Structure (Cefazolin For Injection 1)

Chemical Structure (Cefazolin For Injection 1)
Chemical structure diagram of cefazolin, showing its molecular composition and arrangement including key atoms such as nitrogen, sulfur, and sodium.*
FDA Label Image

Ndc 0143-9924-90 Cefazolin For Injection, Usp 1 Gram*/vial For Iv Or Im Use Rx Only * Each Vial Contains Sterile Cefazolin Sodium Equivalent To 1 Gram Cefazolin. The Sodium Content Is 48 mg. Usual Adu (Cefazolin For Injection 3)

Ndc 0143-9924-90 Cefazolin For Injection, Usp 1 Gram*/vial For Iv Or Im Use Rx Only * Each Vial Contains Sterile Cefazolin Sodium Equivalent To 1 Gram Cefazolin. The Sodium Content Is 48 mg. Usual Adu (Cefazolin For Injection 3)
Cefazolin for Injection, USP 1 gram vial label, indicating the product is for intravenous (IV) or intramuscular (IM) use only. The label includes dosing instructions, storage conditions, and manufacturer information (Hikma Farmacéutica, Portugal) with distribution by West-Ward Pharmaceutical Corp, Eatontown, NJ. The label also notes reconstitution and stability details and emphasizes protection from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.